SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indoco Remedies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532612

INE873D01024

118.1308922

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INDOCO

1765.77

EPS(TTM)

Face Value()

Div & Yield %

0.1

Back

genpharmasec limited

Suratwwala Business Group consolidated net profit rises 3609.09% in the September 2025 quarter

Nov 19,2025

Net profit of Suratwwala Business Group rose 3609.09% to Rs 8.16 crore in the quarter ended September 2025 as against Rs 0.22 crore during the previous quarter ended September 2024. Sales rose 1059.82% to Rs 25.98 crore in the quarter ended September 2025 as against Rs 2.24 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	25.98	2.24	1060
OPM %	42.57	29.91	-
PBDT	11.35	0.86	1220
PBT	10.95	0.75	1360
NP	8.16	0.22	3609

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)